Forbes China's rich list of health care revealed, "medical sister" fire.

On the evening of August 4th, Forbes China released the top 50 list of the richest people in health care.
that the list uses holdings and financial information from wealthy individuals and families, stock exchanges, analysts and Chinese regulators.
list includes both personal and family wealth, including wealth shared by business founders and close relatives.
wealth from listed companies is calculated based on share prices and exchange rates as of July 17.
listed companies are valued on the basis of similar listed companies.
according to Forbes' list of China's richest people in healthcare, Zhong Huixuan, the 59-year-old chairman of Henson Pharmaceuticals' board of directors, topped the list with $19.5 billion ($136.15 billion).
In addition, Meirui Medical co-founder Li Xiting ($17.5 billion), Hengrui Pharmaceutical Group Chairman Sun Fengyang ($16.8 billion), Meirui Medical co-founder Xu Hang ($16.3 billion), Zhifei Bio Jiang Rensheng and family ($16 billion) are among the top five.
Zhong Huixuan is the founder, chairman and CEO of Hansen Pharmaceutical Group, this year, affected by the special period, Hansen Pharmaceuticals' medical and health sector rose rapidly, January 23 to July 17, Hansen Pharmaceuticals' Hong Kong stock price rose 38%, Zhong Huixuan's family also rose, become the rich list of "pharma sister."
statistics, in the nearly seven months from December 19, 2019 to July 17, 2020, Zhong Huixuan's family rose by 50.79 billion yuan, an increase of nearly 60 percent, with an average daily account of about 243 million yuan.
's husband, Sun Yang, chairman of Jiangsu Hengrui Pharmaceutical Group, was ranked third on the list.
, which has broken the 500 billion yuan mark in market capitalisation, rose 31.4 percent, with Sun floating to the top of the list with $16.8 billion.
Hengrui Pharmaceuticals recently released its 2020 half-yearly report, the company achieved operating income of RMB11,309 million in the first half of 2020, up 12.79 percent YoY, and net profit attributable to shareholders of listed companies was RMB2,662 million, up 10.34% YoY.
double-digit growth in revenue and profit, this is the lowest growth rate for Hengrui Pharmaceuticals in nearly a decade.
Meirui Medical, a leading domestic pharmaceutical company, expects revenue growth of 30% in the first half of 2020 from a year earlier (about 8.2 billion yuan a year earlier) and net profit attributable to shareholders of listed companies to be up 48% from a year earlier (about 2.4 billion yuan a year earlier).
between January 23 and July 17, Myer's shares jumped 82%, with co-founders Li Xiting and Xu Hai's family rising to $17.5 billion and $16.3 billion, respectively, ranking second and fourth on the list.
also worth mentioning that on February 26, 2020, Li Xiting ranked 202nd on Hurun's Global Rich List with a fortune of 64 billion yuan.
, Zhifei creature Jiang Rensheng and his family came in fifth with $16 billion.
September 28, 2010, Zhifei Bio was listed on the Shenzhen Stock Exchange GEM, spawning six billionaires.
the same day, the market value of chairman Jiang Rensheng's family's shareholding reached 10.7 billion yuan, of which Jiang Rensheng's personal home was 9.6 billion yuan.
this year, stimulated by a number of factors, Zhifei bio-market value continued to expand, at one point exceeded the 300 billion yuan mark.
282.80 per cent so far this year as of the close of trading on August 3.
the first half of 2020, Zhifei Bio achieved operating income of 6,994 million yuan, up 38.80 percent year-on-year, and realized a net profit of 1.513 billion yuan, up 8.58 percent year-on-year, according to the report.
.